Ovarian Cancer Screening and Symptom Awareness Consensus Statement
Finding a method of early detection for ovarian cancer has been a primary focus of research for years, and was believed to be a promising approach to stopping women, or … Continued
News
OCRA Awards Rosalind Franklin and Liz Tilberis Research Prizes for 2022
OCRA is pleased to award research prizes to Dr. Ursula Matulonis and Dr. Pradeep Chaluvally-Raghavan, two investigators doing groundbreaking and important work in the field of ovarian cancer research. OCRA’s … Continued
OCRA-Funded Study Reveals Role of L1CAM in Development and Spread of HGSOC
A recent study, funded in part by OCRA, has shed new light on how the most common subtype of ovarian cancer develops and metastasizes, by identifying a key molecule that … Continued
OCRA-Funded Research Sheds Light On Ovarian Cancer Resistance to Immunotherapy
As immunotherapies have seen rising success in treating several other cancers, researchers are hard at work uncovering why immunotherapy for ovarian cancer has, so far, proven ineffective. In a study … Continued
Melica Brodeur, MD, MSc | Meet a Scientist
Dr. Melica Brodeur, of Memorial Sloan Kettering Cancer Center, is a 2022 recipient of OCRA’s Mentored Investigator Grant. With her project, “Exploiting SMARCA4 Alterations for New Therapeutics in Ovarian Cancer,” … Continued
2022 Breakthroughs in Ovarian Cancer Research and Treatment
“We are truly in the Golden Age, the Renaissance, if you will, of care for people with ovarian cancer. So much is happening.” Dr. Stephanie Blank Though there is still … Continued
Amrita Salvi, PhD | Meet a Scientist
Dr. Amrita Salvi, of University of Illinois at Chicago, is a 2022 recipient of OCRA’s Mentored Investigator Grant. With her project, “Investigating the Mechanism of Action of PHY34 in HGSOC,” … Continued
Zelei Yang, PhD | Meet a Scientist
Dr. Zelei Yang, of Dana Farber Cancer Institute, is a 2022 recipient of OCRA’s Mentored Investigator Grant. With her project, “Re-engaging the Anti-tumor Immune Response Against Ovarian Cancer,” Dr. Yang … Continued
Gamze Bildik Elcik, PhD | Meet a Scientist
Dr. Gamze Bildik Elcik, postdoctoral fellow in the Department of Experimental Therapeutics at MD Anderson Cancer Center, is a 2022 recipient of OCRA’s Mentored Investigator Grant. With her project, “DIRAS3 … Continued
New Research Points to Persistent Racial Disparities in Ovarian Cancer Care
Recent research published in JNCCN–Journal of the National Comprehensive Cancer Network has shown that there are clear disparities when it comes to which ovarian cancer patients are receiving treatment in accordance with … Continued
Erin Wesley, PhD | Meet a Scientist
Dr. Erin Wesley, of University of Minnesota Twin Cities, is a 2022 recipient of OCRA’s Mentored Investigator Grant. With her project, “Impact of Cytomegalovirus and Inflammation on NK Cells in … Continued
FDA Approves Mirvetuximab Soravtansine-Gynx for Treatment of Platinum-Resistant Ovarian Cancer
In exciting treatment news, the Food and Drug Administration (FDA) has granted accelerated approval to mirvetuximab soravtansine-gynx (trade name Elahere, made by Immunogen, Inc.), for adults with folate receptor alpha … Continued